Lung tumorspheres as a drug screening platform against cancer stem cells
![Thumbnail](/xmlui/bitstream/handle/10234/187394/69463.pdf.jpg?sequence=5&isAllowed=y)
Visualitza/
Impacte
![Google Scholar](/xmlui/themes/Mirage2/images/uji/logo_google.png)
![Microsoft Academico](/xmlui/themes/Mirage2/images/uji/logo_microsoft.png)
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/7053
comunitat-uji-handle3:10234/8639
comunitat-uji-handle4:
INVESTIGACIONMetadades
Títol
Lung tumorspheres as a drug screening platform against cancer stem cellsAutoria
Data de publicació
2019-04Editor
Oxford University Press (OUP)ISSN
0923-7534; 1569-8041Cita bibliogràfica
A. Herreros Pomares, H. Amado, S. Calabuig Fariñas, E. Escorihuela, J. Murga, S. Torres, E. Durendez-Saez, F. Zhang, A. Blasco, A. Navarro, C. Sampedro, E. Jantus-Lewintre, C. Camps. Lung tumorspheres as a drug screening platform against cancer stem cells, Annals of Oncology, volume 30, suppl. 2, 2019, p. ii8, https://doi.org/10.1093/annonc/mdz073.004.Tipus de document
info:eu-repo/semantics/articleVersió de l'editorial
http://www.sciencedirect.com/science/article/pii/S0923753419302406Versió
info:eu-repo/semantics/publishedVersionParaules clau / Matèries
Resum
Treatment resistance and metastasis are linked to cancer stem cells (CSCs). This population represents a promising target, but remains unexplored in lung cancer. The main objective of this study was to characterize ... [+]
Treatment resistance and metastasis are linked to cancer stem cells (CSCs). This population represents a promising target, but remains unexplored in lung cancer. The main objective of this study was to characterize lung CSCs and discover new therapeutic strategies. [-]
Publicat a
Annals of Oncology, 2019, vol. 30, suppl. 2Drets d'accés
info:eu-repo/semantics/openAccess
Apareix a les col.leccions
- QUIO_Articles [702]
Els següents fitxers sobre la llicència estan associats a aquest element: